Your browser doesn't support javascript.
loading
Very early life microbiome and metabolome correlates with primary vaccination variability in children.
Shaffer, Michael; Best, Katharine; Tang, Catherine; Liang, Xue; Schulz, Steven; Gonzalez, Eduardo; White, Cory H; Wyche, Thomas P; Kang, John; Wesseling, Hendrik; Topçuoglu, Begüm D; Cairns, Thomas; Sana, Theodore R; Kaufhold, Robin M; Maritz, Julia M; Woelk, Christopher H; Swaminathan, Gokul; Norton, James E; Pichichero, Michael E.
Afiliação
  • Shaffer M; Exploratory Science Center, Merck & Co., Inc. , Cambridge, Massachusetts, USA.
  • Best K; Exploratory Science Center, Merck & Co., Inc. , Cambridge, Massachusetts, USA.
  • Tang C; Exploratory Science Center, Merck & Co., Inc. , Cambridge, Massachusetts, USA.
  • Liang X; Exploratory Science Center, Merck & Co., Inc. , Cambridge, Massachusetts, USA.
  • Schulz S; Rochester General Hospital Research Institute, Center for Infectious Diseases and Immunology , Rochester, New York, USA.
  • Gonzalez E; Rochester General Hospital Research Institute, Center for Infectious Diseases and Immunology , Rochester, New York, USA.
  • White CH; Exploratory Science Center, Merck & Co., Inc. , Cambridge, Massachusetts, USA.
  • Wyche TP; Exploratory Science Center, Merck & Co., Inc. , Cambridge, Massachusetts, USA.
  • Kang J; Exploratory Science Center, Merck & Co., Inc. , Cambridge, Massachusetts, USA.
  • Wesseling H; Exploratory Science Center, Merck & Co., Inc. , Cambridge, Massachusetts, USA.
  • Topçuoglu BD; Exploratory Science Center, Merck & Co., Inc. , Cambridge, Massachusetts, USA.
  • Cairns T; Exploratory Science Center, Merck & Co., Inc. , Cambridge, Massachusetts, USA.
  • Sana TR; Exploratory Science Center, Merck & Co., Inc. , Cambridge, Massachusetts, USA.
  • Kaufhold RM; Infectious Diseases and Vaccine Research, MRL, Merck & Co., Inc. , West Point, Pennsylvania, USA.
  • Maritz JM; Exploratory Science Center, Merck & Co., Inc. , Cambridge, Massachusetts, USA.
  • Woelk CH; Exploratory Science Center, Merck & Co., Inc. , Cambridge, Massachusetts, USA.
  • Swaminathan G; Exploratory Science Center, Merck & Co., Inc. , Cambridge, Massachusetts, USA.
  • Norton JE; Exploratory Science Center, Merck & Co., Inc. , Cambridge, Massachusetts, USA.
  • Pichichero ME; Rochester General Hospital Research Institute, Center for Infectious Diseases and Immunology , Rochester, New York, USA.
mSystems ; 8(5): e0066123, 2023 Oct 26.
Article em En | MEDLINE | ID: mdl-37610205
ABSTRACT
IMPORTANCE We show that simultaneous study of stool and nasopharyngeal microbiome reveals divergent timing and patterns of maturation, suggesting that local mucosal factors may influence microbiome composition in the gut and respiratory system. Antibiotic exposure in early life as occurs commonly, may have an adverse effect on vaccine responsiveness. Abundance of gut and/or nasopharyngeal bacteria with the machinery to produce lipopolysaccharide-a toll-like receptor 4 agonist-may positively affect future vaccine protection, potentially by acting as a natural adjuvant. The increased levels of serum phenylpyruvic acid in infants with lower vaccine-induced antibody levels suggest an increased abundance of hydrogen peroxide, leading to more oxidative stress in low vaccine-responding infants.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas / Microbiota / Microbioma Gastrointestinal Limite: Child / Humans / Infant Idioma: En Revista: MSystems Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas / Microbiota / Microbioma Gastrointestinal Limite: Child / Humans / Infant Idioma: En Revista: MSystems Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos